He’s already got a head start on this goal through his work this summer with Professor Vincent Jacquemet at the Hôpital du Sacré-Cœur—part of the Université de Montréal—through Mitacs Globalink Research Internships.
After doing her PhD at the University of Saskatchewan and returning to her home province of BC for a residency, Shawnda had a growing concern about how testing for mental illness and cognitive impairment was being done.
Currently, people have to go through lengthy tests of their concentration, learning, memory, reasoning, language, and other skills. Through Elevate, Shawnda began a two-year fellowship with Copeman Healthcare Centre, researching how much this process could be streamlined while maintaining its reliability.
As a research scientist in the Department of Molecular Biology and Biochemistry, Jacque-Lynne has devoted herself to studying cilia — tiny antennae found on the surface of cells, used for sensory processes, such as taste, touch, and smell. Understanding how cilia work is important because when they break down, a person can suffer a range of health problems, such as sterility, obesity, and neurological deficits.
Yet, in the midst of her research, Jacque-Lynne knew her career could benefit from other learning outside the lab.
Chelation Partners’ approach to fighting antibiotic-resistant diseases is a novel one: cutting off their supply of iron. Without iron, bacteria have a tough time growing, and they’re more vulnerable to the effects of antibiotics. What’s more, Chelation Partners has discovered this tactic could also be applied to the fight against cancer. Cancer cells seem to be more sensitive to lower iron levels than other cells in the body, so reducing the availability of the metal might restrict the growth of cancer and boost the effectiveness of chemotherapy and radiation treatment.
Researchers like Yang Yang, a Mitacs Elevate postdoctoral fellow in the Pharmaceutical Orthopaedic Research lab at the University of Alberta, are tackling the problem head-on by developing new treatments for the disease. In partnership with Osteo-Metabolix Pharmaceuticals Inc., Yang has created a new drug that does a better job of healing broken bones.
Once prostate cancer is diagnosed, a series of biopsies has to be done to determine how serious the case is. These can be invasive and painful for the patient and may not give an accurate prognosis.
In partnership with Mitacs-Accelerate intern Julius Adebayo Awe, CancerCare Manitoba has developed an innovative way to determine the progression of prostate cancer in intermediate risk prostate cancer patients through a simple blood test. This work is done in collaboration with the Manitoba Prostate Centre and Drs. Darrel Drachenberg and Jeff Saranchuk.
As a returning Globalink student, Linda was awarded the Mitacs Globalink Graduate Fellowship which provides financial support to former Globalink Research Interns who return to Canada for graduate studies at select Mitacs university partners.
Outside of the laboratory, Vinícius has been building his professional portfolio by attending workshops on networking, time management and communication, a critical component of the Mitacs Elevate program. The skills and confidence he’s acquired have been instrumental in helping him grow as a researcher. “The professional development workshops have provided me with the tools, guidance and knowledge I was lacking as a career student. In particular, they’ve helped me identify which skills I need to improve and strengthen.